FAST vs KZR · P/E 43, rev $4.59B vs $53.9M cap
Fastenal Company (FAST) versus Kezar Life Sciences Inc (KZR) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. KZR currently screens at market cap $53.9M.
Not investment advice. Open the FAST and KZR stock pages for the full models.
Not investment advice.